1.8500
-0.1000
(-5.13%)
At close: January 10 at 3:59:59 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
5,467.9640
12,374.0260
17,381.9200
1,796.2115
Total Liabilities Net Minority Interest
825.9380
5,377.2150
4,179.3230
811.0457
Total Equity Gross Minority Interest
4,642.0260
6,996.8110
13,202.5970
985.1658
Total Capitalization
4,642.0260
6,996.8110
13,202.5970
985.1658
Common Stock Equity
4,642.0260
6,996.8110
13,202.5970
985.1658
Capital Lease Obligations
11.5100
77.5990
--
--
Net Tangible Assets
4,466.7720
6,796.9770
13,000.4720
801.4116
Working Capital
3,773.8450
9,384.2650
15,359.7820
801.4116
Invested Capital
4,642.0260
6,996.8110
13,202.5970
985.1658
Tangible Book Value
4,466.7720
6,796.9770
13,000.4720
801.4116
Total Debt
11.5100
77.5990
--
--
Share Issued
1,998.8480
1,670.0760
1,443.2970
768.3060
Ordinary Shares Number
1,998.8480
1,670.0760
1,443.2970
768.3060
12/31/2020 - 11/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENBI.CN Entheon Biomedical Corp.
0.2750
+7.84%
BX2.DU BioXcel Therapeutics Inc
0.3558
-2.87%
PX91.DU Cassava Sciences Inc
2.7350
+0.92%
PX91.BE Cassava Sciences Inc
2.7360
+0.96%
BX2.F BioXcel Therapeutics, Inc.
0.3673
+0.27%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
0.00%
BX2.MU BioXcel Therapeutics Inc
0.3604
-5.16%
ZVAA.F Cellectis S.A.
1.7100
-7.57%
PX91.F Cassava Sciences, Inc.
2.7800
-1.07%
CYTO.V Cytophage Technologies Ltd.
0.2700
-1.82%